drugset / Trial / NCT06158555
Targeted Perfusion Based Haemodynamic Management in Critically Ill Patients Using Urethral Perfusion
NaSingle-groupOpen-labelDiagnostic
Summary
To assess the safety and feasibility of the IKORUS device in critically ill patients and to gather exploratory data on haemodynamic coherence
Timeline
- Start
- 2023-04-01
- Primary completion
- 2024-06-01
- Completion
- 2024-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | sodium chloride | Unknown | 250 ml | — |
Indications
No indication recorded.